Macrobid and Skelaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) and Skelaxin (metaxalone). Common drug interactions include speech disorder among females and scar among males.

The phase IV clinical study analyzes what interactions people have when they take Macrobid and Skelaxin. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

What is Skelaxin?

Skelaxin has active ingredients of metaxalone. It is often used in back pain. eHealthMe is studying from 9,706 Skelaxin users. Check the latest studies of Skelaxin.



On Jul, 12, 2026

87 people who take Macrobid and Skelaxin together, and have interactions are studied.

Macrobid and Skelaxin drug interactions.

What are the common drug interactions of Macrobid and Skelaxin, by gender? *:

female:

  1. Speech disorder
  2. Dry mouth
  3. Dyspnoea (difficult or laboured respiration)
  4. Oropharyngeal pain
  5. Hypertension (high blood pressure)
  6. Pain
  7. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Cough
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

male:

  1. Scar
  2. Acute sinusitis
  3. Candidiasis (candidiasis or thrush is a fungal infection)
  4. Cellulitis (infection under the skin)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  7. Constipation
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Decreased appetite
  10. Device related infection

What are the common drug interactions of Macrobid and Skelaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Scar
  2. Acute sinusitis
  3. Anaemia (lack of blood)
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Arthropathy
  9. Bone disorder
  10. Bone loss

10-19:

n/a

20-29:

  1. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

  1. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  2. Hyperglycaemia (high blood sugar)
  3. Insomnia (sleeplessness)
  4. Sleep disorder
  5. Type 2 diabetes mellitus
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Drug hypersensitivity
  8. Erythema multiforme (a type of hypersensitivity reaction)
  9. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  10. Neck pain

40-49:

  1. Headache (pain in head)
  2. Chest pain
  3. Speech disorder
  4. Neck pain
  5. Vision blurred
  6. Abdominal distension
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  9. Anxiety
  10. Intermenstrual bleeding

50-59:

  1. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Joint effusion (presence of extra fluid in joint covering)
  5. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
  6. Panic reaction
  7. Psychogenic pain disorder
  8. Social avoidant behaviour (avoiding social connection a personality disorder)
  9. Substance-induced psychotic disorder
  10. Abdominal pain

60+:

  1. Diarrhoea
  2. Anxiety
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Aortic arteriosclerosis (hardening of the aortic arteries)
  5. Discomfort
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Emotional distress
  8. Feeling jittery
  9. Fractured sacrum
  10. Gingival bleeding (bleeding gums)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 24 people, 27.59%
  2. Multiple Myeloma (cancer of the plasma cells): 14 people, 16.09%
  3. Depression: 11 people, 12.64%

* Approximation only. Some reports may have incomplete information.

Do you take Macrobid and Skelaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Macrobid and Skelaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Skelaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Skelaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin; nitrofurantoin, macrocrystalline and metaxalone (the active ingredients of Macrobid and Skelaxin, respectively), and Macrobid and Skelaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: